Everette Lee DeGolyer

GeoPark Announces 2P Reserve Replacement of 110%

Retrieved on: 
Wednesday, February 21, 2024

All reserves included in this release refer to GeoPark working interest before royalties paid in kind, except when specified.

Key Points: 
  • All reserves included in this release refer to GeoPark working interest before royalties paid in kind, except when specified.
  • During 2023, GeoPark added 14.0 mmboe of net 2P reserves, which after producing 12.7 mmboe resulted in 2P reserves of 115.1 mmboe, representing a 110% 2P Reserve Replacement Ratio (RRR).
  • The improved recovery from the horizontal well drilling campaign and waterflooding projects in the Llanos 34 Block (GeoPark operated, 45% WI) also added 2P reserves.
  • D&M estimated future development capital required to develop 1P reserves at $126 million, and $310 million to develop 2P reserves.

Ecopetrol registered 1,883 million barrels of oil equivalent of Proven Reserves by year-end 2023

Retrieved on: 
Thursday, February 29, 2024

The ratio of reserves to production or average reserve life of the Ecopetrol Group is 7.6 years.

Key Points: 
  • The ratio of reserves to production or average reserve life of the Ecopetrol Group is 7.6 years.
  • At year-end 2023, the net proven reserves of the Ecopetrol Group amounted to 1,883 million barrels of oil equivalent, maintaining the average levels of the last 9 years.
  • In 2023, proven developed reserves grew around 4% compared to 2022, evidencing an improvement in the Company's execution capacity.
  • Ecopetrol Group Proven Reserves as of December 31, 2023
    Proven Reserves as of Dic 31, 2022

Epsilon Energy Ltd. Announces Full Year 2022 Results and Approval of New Share Repurchase Program

Retrieved on: 
Friday, March 24, 2023

HOUSTON, March 23, 2023 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported its financial results for the fourth quarter and full-year ended December 31, 2022.

Key Points: 
  • HOUSTON, March 23, 2023 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported its financial results for the fourth quarter and full-year ended December 31, 2022.
  • Cash and cash equivalents (including restricted cash) was $45.8 million at December 31, 2022, an increase of 69% compared to December 31, 2021.
  • Epsilon generated revenues of $15.2 million for the quarter ended December 31, 2022, compared to $13.8 million in the same period last year.
  • Participants should ask to be joined to the “Epsilon Energy Year End 2022 Earnings Conference Call”
    A webcast can be viewed at:
    https://event.choruscall.com/mediaframe/webcast.html?webcastid=oXVnHGHH .

Genel Energy PLC: Update on year-end 2022 oil reserves

Retrieved on: 
Thursday, March 16, 2023

International petroleum consultants DeGolyer and MacNaughton, working on behalf of the operator DNO, assess that Tawke licence (Genel 25% working interest) gross year-end 2022 2P reserves stood at 327 MMbbls, compared to 357 MMbbls at year-end 2021, after adjusting for production of 39 MMbbls and an upward technical revision of 9 MMbbls.

Key Points: 
  • International petroleum consultants DeGolyer and MacNaughton, working on behalf of the operator DNO, assess that Tawke licence (Genel 25% working interest) gross year-end 2022 2P reserves stood at 327 MMbbls, compared to 357 MMbbls at year-end 2021, after adjusting for production of 39 MMbbls and an upward technical revision of 9 MMbbls.
  • Following implementation and observation of the performance of phase 1 of the Tawke field Enhanced Oil Recovery project, Genel has moved 11.7 MMbbls of the 23.3 MMbbls of those gross 2P reserves that were previously included as 2C resources into 2P reserves.
  • At Taq Taq (44% working interest, joint operator), gross 2P reserves stood at 24 MMbbls at year-end 2022 (26 MMbbls at end-2021), following production of 1.6 MMbbls.
  • At Sarta (30% working interest, operator) Genel’s estimate of gross 2P reserves at year-end 2022 is 9 MMbbls (32 MMbbls at the end of 2021), following production of 1.7 MMbbls and a technical revision after assessment of the results of the 2022 appraisal wells and pilot production.

Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovation in Cancer Care Beyond Medicine

Retrieved on: 
Monday, August 8, 2022

NORTHBROOK, Ill., Aug. 8, 2022 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the winner of the sixth annual C3 (Changing Cancer Care) Prize, a global challenge that funds and advances the best non-treatment ideas to improve cancer care for patients, caregivers and the broader oncology community. Aimee DeGolyer, Founder & CEO of REPROSENT, based in Los Gatos, California, was chosen as the 2022 Grand Prize winner and will receive a $100,000 grant plus additional resources and hands-on support.

Key Points: 
  • NORTHBROOK, Ill., Aug. 8, 2022 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the winner of the sixth annual C3 (Changing Cancer Care) Prize, a global challenge that funds and advances the best non-treatment ideas to improve cancer care for patients, caregivers and the broader oncology community.
  • A panel of volunteer judges who are leaders in innovation, healthcare and business selected the Grand Prize winner.
  • The Astellas Oncology C3Prize, launched in 2016, is a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine.
  • The C3Prize directly reflects the mission of Astellas Oncology: striving to make every day better for those impacted by cancer.

Allen Barron retires from Graves & Co. Consulting, Bill Vail to serve as Executive Vice President

Retrieved on: 
Monday, March 14, 2022

Consulting, a professional independent reservoir engineering firm to the oil and gas industry, announced today thatAllen C. Barron, Executive Vice President, retired fromGraves & Co. Consultingon March 11, 2022, after a distinguished 50+year career in the energy industry.

Key Points: 
  • Consulting, a professional independent reservoir engineering firm to the oil and gas industry, announced today thatAllen C. Barron, Executive Vice President, retired fromGraves & Co. Consultingon March 11, 2022, after a distinguished 50+year career in the energy industry.
  • "On behalf of all of our Graves colleagues, I want to extend our deepest thanks to Allen," said John L. Graves, President.
  • "Allen has contributed a great deal to the success of Graves & Co.
  • Consulting also announced today that William W. "Bill" Vail, Jr.,who currently serves as Senior Reservoir Engineer, has been promoted to Executive Vice President effective March 14, 2022.

Abraxas Provides Reserve and Operational Update

Retrieved on: 
Monday, February 28, 2022

Abraxas Petroleum Corporation (Abraxas or the Company) (OTCQX:AXAS) today provided the following reserve and operational update.

Key Points: 
  • Abraxas Petroleum Corporation (Abraxas or the Company) (OTCQX:AXAS) today provided the following reserve and operational update.
  • According to its recently received reserve report, as of December 31, 2021, Abraxas proved oil and natural gas reserves consisted of approximately 24.1MMBoe, a net increase of 8.5 MMBoe over 2020 year-end reserves of 15.6 MMBoe.
  • The independent reserve engineering firm DeGolyer and MacNaughton (D&M) prepared a complete engineering analysis on roughly 95% of Abraxas proved reserves on a Boe basis.
  • The following table outlines changes in Abraxas proved reserves as of December 31, 2021 vs December 31, 2020 (Delaware Basin assets only):

Ranger Announces Growth in Total Proved and Proved Developed Reserves of 90% and 82%, Respectively

Retrieved on: 
Tuesday, February 22, 2022

HOUSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Ranger Oil Corporation ("Ranger" or the "Company") (NASDAQ: ROCC) announced today its total proved reserves for year end 2021, the expected achievement of its 1.0x leverage(1) target, and the Company's fourth quarter 2021 earnings release date.

Key Points: 
  • The composition of Ranger's reserves at the end of 2021 was 68% oil, 17% NGLs and 15% natural gas, with 38% of the reserves classified as proved developed.
  • The guidance provided in this release does not constitute any form of guarantee or assurance that the matters indicated will be achieved.
  • Ranger's estimated proved reserves were prepared by DeGolyer and MacNaughton (D&M), the Company's independent third-party reserve engineers.
  • We use non-GAAP PV-10 value as one measure of the value of our estimated proved reserves and to compare relative values of proved reserves amount exploration and production companies without regard to income taxes.

Genel Energy PLC: Update on year-end 2021 oil reserves

Retrieved on: 
Monday, February 21, 2022

Pending further analysis of the performance of the Enhanced Oil Recovery project, Genel continues to hold 23 MMbbls of those 2P gross reserves in 2C resources.

Key Points: 
  • Pending further analysis of the performance of the Enhanced Oil Recovery project, Genel continues to hold 23 MMbbls of those 2P gross reserves in 2C resources.
  • At Taq Taq (44% working interest, joint operator), 2P gross reserves stood at 26 MMbbls at year-end 2021 (33 MMbbls at end-2020), following a downward technical revision of 5 MMbbls and production of 2 MMbbls.
  • McDaniel & Associates carried out the independent assessment of the Taq Taq licence.
  • Flow testing of Sarta-1D is currently ongoing, and the appraisal results of Sarta-5 and Sarta-6 will be incorporated into our assessment of the reserves of Sarta at the appropriate time.

EY announces Don DeGolyer of Vertice Pharma as Entrepreneur Of The Year® 2018 Award winner in New Jersey region

Retrieved on: 
Monday, July 16, 2018

NEW PROVIDENCE, N.J., July 16, 2018 /PRNewswire/ --EY announced that Don DeGolyer, Founder & CEO of Vertice Pharma, received the Entrepreneur Of The Year 2018 Award in the Emerging Company category in the New Jersey region.

Key Points: 
  • NEW PROVIDENCE, N.J., July 16, 2018 /PRNewswire/ --EY announced that Don DeGolyer, Founder & CEO of Vertice Pharma, received the Entrepreneur Of The Year 2018 Award in the Emerging Company category in the New Jersey region.
  • The award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities.
  • Don was selected by an independent panel of judges, and the award was presented at a special gala event at the Hyatt Regency in New Brunswick, New Jersey on June 28, 2018.
  • "On behalf of our entire 200 dedicated Vertice employees, I am honored to receive this award and recognition for the work we do on behalf of patients everyday," commented, DeGolyer.